Urinary quantification of APOA2 protein was decscribed, which is a biomarker for the diagnosis of bladder cancer (Chen et al., 2015), and APOA2 had higher expression in liver tissues (Fukuhara et al., 2014), which differ from our study, consider cell heterogeneity. This evidence concerns the gene APOA2 and urinary bladder carcinoma.